Propel Bio Management, LLC / KYTX
Propel Bio Management, LLC’s Kyverna Therapeutics Inc Position
Does Propel Bio Management, LLC own Kyverna Therapeutics Inc (KYTX)? Yes — 644.4K shares worth $6M (+3.52% of its 13F portfolio) as of Q1 2026, down from 666.7K shares the prior filed quarter.
Position Value
$6M
Q1 2026
Shares
644.4K
% of Portfolio
+3.52%
Quarters Held
2
currently held
Position History KYTX
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Propel Bio Management, LLC’s full portfolio or all institutional holders of KYTX.